Value of cannulated prolactin testing in identifying true hyperprolactinaemia in females of reproductive age
Clinical Endocrinology · 2024
DOI: 10.1111/cen.15048 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Su Ann Tee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, UK. Hauptthemen laut MEDLINE: Hyperprolactinemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, UK.
- Department of Endocrinology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
Zitieren
APA
Tee, S. A., Gad, H., Boot, C., James, A., Mamoojee, Y., & RVI Endocrine Group (2024). Value of cannulated prolactin testing in identifying true hyperprolactinaemia in females of reproductive age. Clinical Endocrinology. https://doi.org/10.1111/cen.15048
Vancouver
Tee SA, Gad H, Boot C, James A, Mamoojee Y, RVI Endocrine Group. Value of cannulated prolactin testing in identifying true hyperprolactinaemia in females of reproductive age. Clinical Endocrinology. 2024. doi:10.1111/cen.15048
BibTeX
@article{Tee2024,
author = {Tee, Su Ann and Gad, Hady and Boot, Christopher and James, Andy and Mamoojee, Yaasir and RVI Endocrine Group, RVI Endocrine Group},
title = {Value of cannulated prolactin testing in identifying true hyperprolactinaemia in females of reproductive age},
journal = {Clinical Endocrinology},
year = {2024},
doi = {10.1111/cen.15048}
}
EUVIMED